Press release distribution, EDGAR filing, XBRL, regulatory filings

CAT-1004, a NF-KB inhibitor, is expected to enter a Phase 2 clinical trial in th... )--Medidata , the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it will host a financial analyst... )--Rambus Inc. today announced that its Cryptography Research division has licensed select security-related technologies to Cisco Systems.

http://ift.tt/1pfgQdU